Mankind Pharma - Stock Investment Idea Weekly Pick
Mankind Pharma has recovered from its ₹2100–₹2200 base and broken out of a triangle pattern, closing above anchored VWAP and Ichimoku cloud. The stock is forming higher bottoms, with RSI above 60 and MACD in bullish crossover, signaling strong momentum. Accumulate ₹2640–₹2680 for ₹3000–₹3150. Stop loss: ₹2410.
Expert recommendation by Mr. Ketan Kaushik - Derivative Analyst (NISM - 202200162803)
- Current Price: ₹2660
- Buying Price: ₹2640 - ₹2680
- Target Price: ₹3000 - ₹3150
- Stop loss: ₹2410
- Upside: 18%
- Time Frame: 6-8 Weeks
Stock Technical Analysis
- Stock made an all-time high at 3054 in Dec24; after making highs, stock had witnessed sharp correction and takes support in 2100-2200 zone
- Stock has given a breakout from the triangle chart pattern and closed above anchored VWAP resistance level
- Stock has been making higher bottom formation since last few days and it has given breakout above ichimoku cloud
- Momentum indicator RSI has given breakout above 60 level and MACD has also given bullish crossover above 0 level on the daily chart which indicates upside momentum is likely to continue in the coming days
Traders can look to accumulate MANKIND in the 2640-2680 zone and expect upside targets of 3000-3150 in 6-8 weeks with stop loss below 2410 (closing basis).
Click this link for a deeper understanding of swing trading strategies.
Know more about Mankind Pharma – Value Pharma with Scale, Innovation & Expansion
Website: https://www.mankindpharma.com/
Sector: Pharmaceuticals & Healthcare sector
- Founded in 1991, commenced full operations around 1995.
- Headquartered in Delhi, with a strong domestic presence and growing international reach (operating in 30-35+ countries)
- Business verticals:
- Pharmaceutical Formulations (both acute & chronic therapeutic areas: anti-infectives, cardiovascular, gastrointestinal, respiratory, CNS, etc.)
- Consumer Healthcare / OTC & FMCG Brands — known brands like Manforce (condoms), Prega News (pregnancy test kits), Unwanted-72, HealthOK, Gas-O-Fast, AcneStar etc.
- APIs, soft & hard gels, injectables, and other complex dosage forms; significant R&D investments; diversified manufacturing capabilities across many dosage forms.
Disclaimer - Investments in securities market are subject to market risk, read all the related document carefully before investing.
https://www.mnclgroup.com/
